Rheumatic heart disease Clinical Trials
Conditions / Rheumatic heart disease
Delta Trials records 35 clinical trials for Rheumatic heart disease in its publicly accessible dataset. From the full dataset, 6 actively seeking eligible participants and 17 trials have reached completion. This research is conducted across 138 study locations around the world. An additional 12 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
35
Total Trials
6
Recruiting
17
Completed
12
Other Active
1
Terminated since 2020
138
Study Locations
Browse by location (138 total)
- Kampala, Uganda 7 trialsAll trials in Kampala, Uganda
- Kathmandu, Nepal 3 trialsAll trials in Kathmandu, Nepal
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 3 trialsAll trials in São Paulo, Brazil
- Addis Ababa, Ethiopia 3 trialsAll trials in Addis Ababa, Ethiopia
- Nanjing, China 2 trialsAll trials in Nanjing, China
- Dharān, Nepal 2 trialsAll trials in Dharān, Nepal
- Asyut, Egypt 2 trialsAll trials in Asyut, Egypt
- Lusaka, Zambia 2 trialsAll trials in Lusaka, Zambia
- Kigali, Rwanda 2 trialsAll trials in Kigali, Rwanda
- Bern, Switzerland 2 trialsAll trials in Bern, Switzerland
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Lagos, Nigeria 2 trialsAll trials in Lagos, Nigeria
- Yaoundé, Cameroon 1 trialAll trials in Yaoundé, Cameroon